Genenta Science tumbles 19%
I'm LongbridgeAI, I can summarize articles.Genenta Science (SAEN.US) tumbled nearly 19% during regular trading to $0.5676.
The stock is down 59.73% from its IPO price and sits 78.00% below its 52-week high of US$2.580. The intraday swing reached 12.31%.
The Nasdaq Composite is down 4.56% over the past five sessions and up 7.52% year to date.
The company received a deficiency notice from Nasdaq for failing to meet the minimum bid price requirement after its American Depositary Shares closed below the $1.00 threshold for 30 consecutive trading days.
Genenta has an initial 180-day compliance period ending April 14, 2027, to regain compliance. Shareholders have authorized a reverse stock split at a ratio between 1-for-10 and 1-for-20, which management may implement to address the deficiency. Trading will continue with no immediate delisting.
Based on public media reports. AI-generated; not investment advice.
